Mr. Speaker, I thank the hon. member for her comments.
I want her to know that we share her concerns about the use of any device or product such as breast implants. We share her concerns about their possible effects on health in the short and long terms, if they are improperly used.
That is why the minister was absolutely proactive in ensuring that the review for certifying these products, which require permits in Canada, is completely transparent. In other countries, experts like our departmental ones who assess every drug and device, have approved these products, but without the necessary transparency to allow people to understand their full scope.
The minister went a little further. He asked a panel of experts to conduct a public study. He then gave the public the opportunity to give its opinion on these issues. This panel will give the minister the answers to specific questions.
However, the decision will not be made by the panel; it remains the responsibility of the minister and must be based on the safety and effectiveness of these products. Then a decision will be made based on the responses to these questions.